Figure S3 from Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Mam-A vaccination elicits specific immunity to multiple Mam-A epitopes
Fields of Study & Subjects
Immunotherapy and Immune Responses
Breast Cancer Treatment Studies
Cancer Immunotherapy and Biomarkers
Publication details
- Publication date
- 2 April 2026
- Language
- EN